Yanncik von Grabowiecki
Rab11-FIP1/RCP functions as a major signalling hub in the oncogenic roles of mutant p53 in cancer
von Grabowiecki, Yanncik; Phatak, Vinaya; Aschauer, Lydia; Muller, Patricia AJ
Authors
Abstract
Rab11-FIP1 is a Rab effector protein that is involved in endosomal recycling and trafficking of various molecules throughout the endocytic compartments of the cell. The consequence of this can be increased secretion or increased membrane expression of those molecules. In general, expression of Rab11-FIP1 coincides with more tumourigenic and metastatic cell behaviour. Rab11-FIP1 can work in concert with oncogenes such as mutant p53, but has also been speculated to be an oncogene in its own right. In this perspective, we will discuss and speculate upon our observations that mutant p53 promotes Rab11-FIP1 function to not only promote invasive behaviour, but also chemoresistance by regulating a multitude of different proteins.
Citation
von Grabowiecki, Y., Phatak, V., Aschauer, L., & Muller, P. A. (2021). Rab11-FIP1/RCP functions as a major signalling hub in the oncogenic roles of mutant p53 in cancer. Frontiers in Oncology, 11, Article 804107. https://doi.org/10.3389/fonc.2021.804107
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 3, 2021 |
Online Publication Date | Dec 21, 2021 |
Publication Date | 2021 |
Deposit Date | Dec 16, 2021 |
Publicly Available Date | Jan 25, 2022 |
Journal | Frontiers in Oncology |
Electronic ISSN | 2234-943X |
Publisher | Frontiers Media |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Article Number | 804107 |
DOI | https://doi.org/10.3389/fonc.2021.804107 |
Public URL | https://durham-repository.worktribe.com/output/1219432 |
Files
Published Journal Article
(3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
Copyright © 2021 von Grabowiecki, Phatak, Aschauer and Muller. This is an openaccess article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply with
these terms.
You might also like
GOF Mutant p53 in Cancers: A Therapeutic Challenge
(2022)
Journal Article
Ultraviolet light-induced collagen degradation inhibits melanoma invasion
(2021)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search